Oncolytics Biotech® Announces Upcoming Investor Conferences in September

SAN DIEGO, Aug. 28, 2025 /PRNewswire/ -- Oncolytics Biotech^® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, will participate in two investor conferences next month. CEO Jared Kelly will be meeting with institutional investors at the H.C. Wainwright 27^th Annual Global Investment Conference and the Lake Street Capital Markets 9^th Annual Best Ideas Growth Conference. Additional details for both of these events can be found below.

Read more at prnewswire.com